To contact us, please fill in the form below.
PROs in the news
- Supplemental BLA for New Nivolumab Dosing Schedule Accepted by FDA
- Sector Market Growth in Legalization of Cannabis
- BeiGene to use Medidata's ePRO solution for oncology studies
- Patient Questionnaires Can Predict Clinical Outcomes in Patients With Multiple Sclerosis
- Phase 2/3 Trial of Elamipretide to Treat Barth Syndrome Now Enrolling Patients